No. S 200
Misuse of Drugs Act
(CHAPTER 185)
Misuse of Drugs Act (Amendment of First and
Fifth Schedules) Order 2016
In exercise of the powers conferred by sections 58A and 59 of the Misuse of Drugs Act, the Minister for Home Affairs makes the following Order:
Citation and commencement
1.  This Order is the Misuse of Drugs Act (Amendment of First and Fifth Schedules) Order 2016 and comes into operation on 1 May 2016.
Amendment of Part I of First Schedule
2.  Part I of the First Schedule to the Misuse of Drugs Act is amended —
(a)by deleting items (21), (38), (49), (62), (84) and (127) of paragraph 1;
(b)by deleting item (1) of paragraph 7 and substituting the following items:
(1)Acetylfentanyl (also known as desmethyl fentanyl)
(1A)Alfentanil”;
(c)by inserting, immediately after item (12) of paragraph 7, the following item:
(12A)Thiafentanil”;
(d)by deleting items (2A) and (2B) of paragraph 18 and substituting the following items:
(2A)2-Amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one (also known as bk-2C-B) and its bromo and dimethoxy positional isomers in the phenyl ring
(2B)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as MAB-CHMINACA)
(2C)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-ADB-PINACA) and its fluoro positional isomers in the pentyl group
(2D)N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as ADB-PINACA)
(2E)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide (also known as 5-Chloro-AB-PINACA) and its chloro positional isomers in the pentyl group
(2F)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (also known as AB-CHMINACA)
(2G)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (also known as AB-FUBINACA) and its fluoro positional isomers in the phenyl ring
(2H)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as 5-Fluoro-AB-PINACA) and its fluoro positional isomers in the pentyl group
(2I)N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (also known as AB-PINACA)
(2J)N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (also known as PX-2) and its fluoro positional isomers in the pentyl group
(2K)N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (also known as PX-1) and its fluoro positional isomers in the pentyl group
(2L)4-(2-Aminopropyl)benzofuran (also known as 4-APB)”;
(e)by inserting, immediately after item (6A) of paragraph 18, the following item:
(6AA)1-(1-Benzofuran-5-yl)-N-ethylpropan-2-amine (also known as 5-EAPB) and its 4-yl, 6-yl and 7-yl isomers”;
(f)by inserting, immediately after item (8A) of paragraph 18, the following item:
(8B)1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (also known as MT-45)”;
(g)by inserting, immediately after item (15A) of paragraph 18, the following item:
(15B)2-(2,5-Dimethoxyphenyl)ethanamine (also known as 2C-H) and its dimethoxy positional isomers in the phenyl ring”;
(h)by inserting, immediately after item (19) of paragraph 18, the following items:
(19A)Ethylphenidate
(19B)[1-(5-Fluoropent-1-yl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone (also known as FUBIMINA) and its fluoro positional isomers in the pentyl group
(19C)[1-(5-Fluoropent-1-yl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (also known as THJ-2201) and its fluoro positional isomers in the pentyl group”;
(i)by deleting item (27A) of paragraph 18 and substituting the following items:
(27A)1-(1H-Indol-5-yl)propan-2-amine (also known as 5-IT) and its 4-yl, 6-yl and 7-yl isomers
(27B)2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (also known as 25I-NBOMe)
(27C)2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (also known as 2C-I) and its dimethoxy and iodo positional isomers in the phenyl ring”;
(j)by inserting, immediately after item (28) of paragraph 18, the following items:
(28A)Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMINACA)
(28B)Methyl 2-[1-(cyclohexylmethyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as MA-CHMINACA)
(28C)Methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamido]-3-methylbutanoate (also known as 5-Fluoro-AMB) and its fluoro positional isomers in the pentyl group”;
(k)by inserting, immediately after item (30) of paragraph 18, the following item:
(30A)4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine (also known as 4,4’-Dimethylaminorex, 4,4’-DMAR or para-methyl-4-methylaminorex) and its methyl positional isomers in the phenyl ring”;
(l)by deleting item (33) of paragraph 18 and substituting the following item:
(33)N-Methyl-1-(thiophen-2-yl)propan-2-amine (also known as methiopropamine) and its thiophen-3-yl isomer”; and
(m)by inserting, immediately after paragraph 18, the following paragraph:
19.  Any compound (other than serotonin) structurally derived from 2-(1H-indol-3-yl)ethanamine (also known as tryptamine) by modification in any of the following ways:
(a)substitution at the nitrogen atom of the side chain to any extent with alkyl or alkenyl substituents, or by inclusion of only the nitrogen atom of the side chain in a cyclic structure;
(b)substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;
(c)substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, hydroxy, thioalkyl, alkylenedioxy, halide or acetoxy substituents;
(d)substitution at the 2-position of the tryptamine ring system with an alkyl substituent,
including any ether, salt or stereoisomeric form of any such compound, any preparation or product containing any such compound, and the following examples of such a compound:
(1)4-Acetoxy-N,N-diisopropyltryptamine (also known as 4-Acetoxy-DiPT or 4-AcO-DiPT)
(2)4-Acetoxy-N,N-dimethyltryptamine (also known as 4-Acetoxy-DMT or 4-AcO-DMT)
(3)5-Benzyloxytryptamine
(4)5-Bromo-N,N-dimethyltryptamine (also known as 5-Bromo-DMT)
(5)5-Bromotryptamine
(6)5-Chloro-α-methyltryptamine (also known as 5-Chloro-AMT)
(7)5-Chlorotryptamine
(8)N,N-Diallyltryptamine
(9)N,N-Diethyltryptamine
(10)N,N-Diisopropyltryptamine
(11)N,N-Dimethyltryptamine
(12)N,N-Dipropyltryptamine
(13)Etryptamine
(14)5-Fluoro-N,N-dimethyltryptamine (also known as 5-Fluoro-DMT)
(15)5-Fluoro-α-methyltryptamine (also known as 5-Fluoro-AMT)
(16)5-Fluorotryptamine
(17)4-Hydroxy-N,N-diethyltryptamine (also known as 4-Hydroxy-DET or 4-HO-DET)
(18)4-Hydroxy-N,N-diisopropyltryptamine (also known as 4-Hydroxy-DiPT or 4-HO-DiPT)
(19)4-Hydroxy-N,N-dimethyltryptamine (also known as Psilocin)
(20)4-Hydroxy-N-methyl-N-ethyltryptamine (also known as 4-Hydroxy-MET or 4-HO-MET)
(21)4-Hydroxy-N-methyl-N-isopropyltryptamine (also known as 4-Hydroxy-MiPT or 4-HO-MiPT)
(22)4-Hydroxy-α-methyltryptamine (also known as 4-Hydroxy-AMT or 4-HO-AMT)
(23)5-Hydroxy-N-methyltryptamine (also known as 5-Hydroxy-NMT or 5-HO-NMT)
(24)5-Hydroxy-N,N-dimethyltryptamine (also known as Bufotenine)
(25)5-Methoxy-N,N-diallyltryptamine (also known as 5-Methoxy-DALT or 5-MeO-DALT)
(26)5-Methoxy-N,N-diethyltryptamine (also known as 5-Methoxy-DET or 5-MeO-DET)
(27)5-Methoxy-N,N-diisopropyltryptamine (also known as 5-Methoxy-DiPT or 5-MeO-DiPT)
(28)5-Methoxy-N,N-dimethyltryptamine (also known as 5-Methoxy-DMT or 5-MeO-DMT)
(29)5-Methoxy-N,N-dipropyltryptamine (also known as 5-Methoxy-DPT or 5-MeO-DPT)
(30)5-Methoxy-N-ethyl-N-isopropyltryptamine (also known as 5-Methoxy-EiPT or 5-MeO-EiPT)
(31)5-Methoxy-N-ethyl-N-propyltryptamine (also known as 5-Methoxy-EPT or 5-MeO-EPT)
(32)5-Methoxy-α-ethyltryptamine (also known as 5-Methoxy-AET or 5-MeO-AET)
(33)5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5-Methoxy-MiPT or 5-MeO-MiPT)
(34)5-Methoxy-α-methyltryptamine (also known as 5-Methoxy-AMT or 5-MeO-AMT)
(35)5-Methoxy-N-methyltryptamine (also known as 5-Methoxy-NMT or 5-MeO-NMT)
(36)4-Methyl-α-ethyltryptamine (also known as 4-Methyl-AET)
(37)5-Methyltryptamine
(38)α-Methyltryptamine
(39)N-Methyltryptamine”.
Deletion and substitution of Fifth Schedule
3.  The Fifth Schedule to the Misuse of Drugs Act is deleted and the following Schedule substituted therefor:
FIFTH SCHEDULE
Sections 24, 26, 27, 32 and 58A
Temporarily listed drugs
1.  The following compounds, including any salt or stereoisomeric form of such compounds, and any preparation or product containing such compounds:
(1)Methyl 2-[1-(cyclohexylmethyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate (also known as MDMB-CHMICA).
(2)Naphthalen-1-yl[1-(pent-1-yl)-1H-indazol-3-yl]methanone (also known as THJ-018).
(3)Naphthalen-1-yl 5-fluoropent-1-yl-1H-indole-3-carboxylate (also known as NM-2201 or CBL-2201) and its fluoro positional isomers in the pentyl group.
(4)5-Fluoropent-1-yl-N-naphthalen-1-yl-1H-indole-3-carboxamide (also known as CBM-2201, 5-Fluoro-NNEI, 5F-NNEI or MN-24F) and its fluoro positional isomers in the pentyl group.”.
Made on 29 April 2016.
LEO YIP
Permanent Secretary,
Ministry of Home Affairs,
Singapore.
[112/2/0049; AG/LEGIS/SL/185/2015/1 Vol. 1]